Cargando…
Botulinum Toxin Treatment for Depression: A New Paradigm for Psychiatry
Multiple randomized double-blind placebo-controlled trials have shown that botulinum toxin A (BoNT/A), when injected into the frown musculature, is an antidepressant. This review outlines the conceptual narrative behind this treatment modality, starting with theory developed by Charles Darwin. We de...
Autor principal: | Finzi, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224294/ https://www.ncbi.nlm.nih.gov/pubmed/37235370 http://dx.doi.org/10.3390/toxins15050336 |
Ejemplares similares
-
Treatment of Depression with Botulinum Toxin
por: Wollmer, Marc Axel, et al.
Publicado: (2022) -
Use of botulinum toxin type a in psychiatry - new perspectives and future potential
por: Viegas, F. Gonçalves, et al.
Publicado: (2021) -
Botulinum Toxin in the Treatment of Headache
por: Becker, Werner J.
Publicado: (2020) -
Botulinum toxin A for the Treatment of Overactive Bladder
por: Hsieh, Po-Fan, et al.
Publicado: (2016) -
The safety and efficacy of botulinum toxin A on the treatment of depression
por: Zhang, Qilin, et al.
Publicado: (2021)